Sirijatuphat, R.; Chayangsu, S.; Srisompong, J.; Ruangkriengsin, D.; Thamlikitkul, V.; Tiengrim, S.; Wangchinda, W.; Koomanachai, P.; Rattanaumpawan, P.
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study. Antibiotics 2022, 11, 348.
https://doi.org/10.3390/antibiotics11030348
AMA Style
Sirijatuphat R, Chayangsu S, Srisompong J, Ruangkriengsin D, Thamlikitkul V, Tiengrim S, Wangchinda W, Koomanachai P, Rattanaumpawan P.
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study. Antibiotics. 2022; 11(3):348.
https://doi.org/10.3390/antibiotics11030348
Chicago/Turabian Style
Sirijatuphat, Rujipas, Sunee Chayangsu, Jintana Srisompong, Darat Ruangkriengsin, Visanu Thamlikitkul, Surapee Tiengrim, Walaiporn Wangchinda, Pornpan Koomanachai, and Pinyo Rattanaumpawan.
2022. "Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study" Antibiotics 11, no. 3: 348.
https://doi.org/10.3390/antibiotics11030348
APA Style
Sirijatuphat, R., Chayangsu, S., Srisompong, J., Ruangkriengsin, D., Thamlikitkul, V., Tiengrim, S., Wangchinda, W., Koomanachai, P., & Rattanaumpawan, P.
(2022). Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study. Antibiotics, 11(3), 348.
https://doi.org/10.3390/antibiotics11030348
